Ibuprofen protects low density lipoproteins against oxidative modification
- 22 October 1999
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 65 (22), 2289-2303
- https://doi.org/10.1016/s0024-3205(99)00496-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Ibuprofen inhibits pyrogen-dependent expression of VCAM-1 and ICAM-1 on human endothelial cellsLife Sciences, 1996
- The effects of free radical scavengers on the oxidation of low-density lipoproteins by macrophagesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophagesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
- Lipophilic β-blockers inhibit monocyte and endothelial cell-mediated modification of low density lipoproteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- Effect of ibuprofen in patients with severe sepsisCritical Care Medicine, 1991
- Calcium Antagonists Prevent Monocyte and Endothelial Cell-Induced Modification of Low Density LipoproteinsFree Radical Research Communications, 1991
- The Human Neutrophil Respiratory Burst OxidaseThe Journal of Infectious Diseases, 1990
- Detection and localization of tumor necrosis factor in human atheromaThe American Journal of Cardiology, 1990
- Spin Trapping of Ibuprofen Radicals: Evidence That Ibuprofen is a Hydroxyl Radical ScavengerFree Radical Research Communications, 1990
- The mechanisms of action of nonsteroidal antiinflammatory drugsArthritis & Rheumatism, 1989